{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T23:52:45Z","timestamp":1770421965863,"version":"3.49.0"},"reference-count":100,"publisher":"Elsevier","isbn-type":[{"value":"9780443188800","type":"print"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/bs.apha.2023.03.002","type":"book-chapter","created":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T22:53:52Z","timestamp":1680216832000},"page":"83-110","source":"Crossref","is-referenced-by-count":12,"title":["Prospects for macrolide therapy of asthma and COPD"],"prefix":"10.1016","author":[{"given":"Michael J.","family":"Parnham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Norris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer A.","family":"Kricker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thorarinn","family":"Gudjonsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clive P.","family":"Page","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/bs.apha.2023.03.002_bib1","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41577-021-00538-7","article-title":"Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions","volume":"21","author":"Akdis","year":"2021","journal-title":"Nature Reviews. Immunology"},{"issue":"8","key":"10.1016\/bs.apha.2023.03.002_bib2","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa1104623","article-title":"Azithromycin for prevention of exacerbations of COPD","volume":"365","author":"Albert","year":"2011","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"10.1016\/bs.apha.2023.03.002_bib3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/jac\/dkh519","article-title":"Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?","volume":"55","author":"Amsden","year":"2005","journal-title":"The Journal of Antimicrobial Chemotherapy"},{"issue":"1","key":"10.1016\/bs.apha.2023.03.002_bib4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12931-019-1101-3","article-title":"Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia","volume":"20","author":"Arason","year":"2019","journal-title":"Respiratory Research"},{"issue":"5","key":"10.1016\/bs.apha.2023.03.002_bib5","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1128\/AAC.50.5.1805-1812.2006","article-title":"Novel effects of azithromycin on tight junction proteins in human airway epithelia","volume":"50","author":"Asgrimsson","year":"2006","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"3","key":"10.1016\/bs.apha.2023.03.002_bib6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1440-1843.2006.00845.x","article-title":"Diffuse panbronchiolitis in East Asia","volume":"11","author":"Azuma","year":"2006","journal-title":"Respirology (Carlton, Vic.)"},{"key":"10.1016\/bs.apha.2023.03.002_bib7","first-page":"995","article-title":"Novel aspects of pathogenesis and regeneration mechanisms in COPD","volume":"10","author":"Bagdonas","year":"2015","journal-title":"International Journal of Chronic Obstructive Pulmonary Disease"},{"key":"10.1016\/bs.apha.2023.03.002_bib8","series-title":"Br J Pharmacol","first-page":"1783","article-title":"Azithromycin analogue CSY0073 attenuates lung inflammation induced by LPS challenge","volume":"171","author":"Balloy","year":"2014"},{"issue":"4","key":"10.1016\/bs.apha.2023.03.002_bib9","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.phrs.2012.06.011","article-title":"Anti-inflammatory mechanism of action of azithromycin in LPS-stimulated J774A.1 cells","volume":"66","author":"Banjanac","year":"2012","journal-title":"Pharmacological Research: The Official Journal of the Italian Pharmacological Society"},{"issue":"2","key":"10.1016\/bs.apha.2023.03.002_bib10","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1378\/chest.08-3056","article-title":"Azithromycin attenuates airway inflammation in a noninfectious mouse model of allergic asthma","volume":"136","author":"Beigelman","year":"2009","journal-title":"Chest"},{"issue":"1","key":"10.1016\/bs.apha.2023.03.002_bib11","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1124\/jpet.109.155838","article-title":"Azithromycin and clarithromycin inhibit lipopolysaccharide-induced murine pulmonary neutrophilia mainly through effects on macrophage-derived granulocyte-macrophage colony-stimulating factor and interleukin-1beta","volume":"331","author":"Bosnar","year":"2009","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"4","key":"10.1016\/bs.apha.2023.03.002_bib12","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.intimp.2010.12.010","article-title":"Azithromycin inhibits macrophage interleukin-1beta production through inhibition of activator protein-1 in lipopolysaccharide-induced murine pulmonary neutrophilia","volume":"11","author":"Bosnar","year":"2011","journal-title":"International Immunopharmacology"},{"issue":"13","key":"10.1016\/bs.apha.2023.03.002_bib13","doi-asserted-by":"crossref","first-page":"6111","DOI":"10.1021\/jm300356u","article-title":"N0-substituted-20- O,30-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity","volume":"55","author":"Bosnar","year":"2012","journal-title":"Journal of Medicinal Chemistry"},{"issue":"4","key":"10.1016\/bs.apha.2023.03.002_bib14","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/thoraxjnl-2012-202698","article-title":"Azithromycin for prevention of exacerbations in severe asthma (AZISAST): A\u00a0multicentre randomised double-blind placebo-controlled trial","volume":"68","author":"Brusselle","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/bs.apha.2023.03.002_bib15","series-title":"Macrocycles in Drug Discovery","first-page":"206","article-title":"Anti-inflammatory macrolides to manage chronic neutrophilic inflammation","author":"Burnet","year":"2015"},{"key":"10.1016\/bs.apha.2023.03.002_bib16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.prrv.2019.07.002","article-title":"Azithromycin is the answer in paediatric respiratory medicine, but what was the question?","volume":"34","author":"Bush","year":"2020","journal-title":"Paediatric Respiratory Reviews"},{"issue":"1","key":"10.1016\/bs.apha.2023.03.002_bib17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.15326\/jcopdf.7.1.2019.0146","article-title":"The burden of cough and phlegm in people with COPD: A COPD Patient-Powered Research Network study","volume":"7","author":"Choate","year":"2020","journal-title":"Chronic Obstructive Pulmonary Diseases"},{"issue":"7","key":"10.1016\/bs.apha.2023.03.002_bib18","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00011-012-0470-6","article-title":"Short-term roxithromycin treatment attenuates airway inflammation via MAPK\/NF-kappaB activation in a mouse model of allergic asthma","volume":"61","author":"Ci","year":"2012","journal-title":"Inflammation Research: Official Journal of the European Histamine Research Society"},{"key":"10.1016\/bs.apha.2023.03.002_bib19","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.2147\/COPD.S202580","article-title":"Impact of cough and mucus on COPD patients: Primary insights from an exploratory study with an Online Patient Community","volume":"14","author":"Cook","year":"2019","journal-title":"International Journal of Chronic Obstructive Pulmonary Disease"},{"issue":"2","key":"10.1016\/bs.apha.2023.03.002_bib20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2183\/pjab.87.13","article-title":"Ivermectin, \u2018wonder drug\u2019 from Japan: The human use perspective","volume":"87","author":"Crump","year":"2011","journal-title":"Proceedings of the Japan Academy. Series B, Physical and Biological Sciences"},{"issue":"1\u20133","key":"10.1016\/bs.apha.2023.03.002_bib21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0014-2999(01)01321-8","article-title":"Anti-inflammatory effects of macrolide antibiotics","volume":"429","author":"Culic","year":"2001","journal-title":"European Journal of Pharmacology"},{"issue":"18","key":"10.1016\/bs.apha.2023.03.002_bib22","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1111\/bph.13936","article-title":"The macrolide antibiotic renaissance","volume":"174","author":"Dinos","year":"2017","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.apha.2023.03.002_bib23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.rmed.2019.06.005","article-title":"Blood eosinophil count and GOLD stage predict response to maintenance azithromycin treatment in COPD patients with frequent exacerbations","volume":"154","author":"Djamin","year":"2019","journal-title":"Respiratory Medicine"},{"issue":"6","key":"10.1016\/bs.apha.2023.03.002_bib24","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1128\/AAC.01424-09","article-title":"Azithromycin alters macrophage phenotype and pulmonary compartmentalization during lung infection with Pseudomonas","volume":"54","author":"Feola","year":"2010","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/bs.apha.2023.03.002_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.975436","article-title":"Pleiotropic effects of antibiotics on T cell metabolism and T cell-mediated immunity","volume":"13","author":"Franz","year":"2022","journal-title":"Frontiers in Microbiology"},{"issue":"4","key":"10.1016\/bs.apha.2023.03.002_bib26","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00056-2019","article-title":"Efficacy of azithromycin in severe asthma from the AMAZES randomised trial","volume":"5","author":"Gibson","year":"2019","journal-title":"ERJ Open Research"},{"issue":"10095","key":"10.1016\/bs.apha.2023.03.002_bib27","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(17)31281-3","article-title":"Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): A randomised, double-blind, placebo-controlled trial","volume":"390","author":"Gibson","year":"2017","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/bs.apha.2023.03.002_bib28","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1183\/09031936.00095809","article-title":"Azithromycin induces anti-viral responses in bronchial epithelial cells","volume":"36","author":"Gielen","year":"2010","journal-title":"The European Respiratory Journal: Official Journal of the European Society for Clinical Respiratory Physiology"},{"key":"10.1016\/bs.apha.2023.03.002_bib29","series-title":"Diagnosis and management","article-title":"Difficult-to-treat & severe asthma in adolescent and adult patients","year":"2022"},{"key":"10.1016\/bs.apha.2023.03.002_bib30","unstructured":"GOLD. (2022). Global strategy for prevention, diagnosis and management of COPD: 2022 Report. Retrieved from www.goldcopd.org: \u3008https:\/\/goldcopd.org\/2021-gold-reports\/\u3009."},{"issue":"1","key":"10.1016\/bs.apha.2023.03.002_bib31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.alit.2017.08.011","article-title":"Role of airway epithelial barrier dysfunction in pathogenesis of asthma","volume":"67","author":"Gon","year":"2018","journal-title":"Allergology International: Official Journal of the Japanese Society of Allergology"},{"issue":"6","key":"10.1016\/bs.apha.2023.03.002_bib32","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00438-18","article-title":"Systematic review, meta-analysis, and network meta-analysis of the cardiovascular safety of macrolides","volume":"62","author":"Gorelik","year":"2018","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"4","key":"10.1016\/bs.apha.2023.03.002_bib33","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/s41591-019-0393-7","article-title":"Intracellular MLCK1 diversion reverses barrier loss to restore mucosal homeostasis","volume":"25","author":"Graham","year":"2019","journal-title":"Nature Medicine"},{"key":"10.1016\/bs.apha.2023.03.002_bib34","doi-asserted-by":"crossref","first-page":"12016","DOI":"10.1038\/srep12016","article-title":"Azithromycin inhibits IL-1 secretion and non-canonical inflammasome activation","volume":"5","author":"Gualdoni","year":"2015","journal-title":"Scientific Reports"},{"issue":"9","key":"10.1016\/bs.apha.2023.03.002_bib35","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1097\/QAD.0000000000001064","article-title":"Bryostatin-1 for latent virus reactivation in HIV-infected patients on antiretroviral therapy","volume":"30","author":"Gutierrez","year":"2016","journal-title":"AIDS (London, England)"},{"issue":"1","key":"10.1016\/bs.apha.2023.03.002_bib36","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1165\/rcmb.2008-0357OC","article-title":"Azithromycin maintains airway epithelial integrity during Pseudomonas aeruginosa infection","volume":"42","author":"Halldorsson","year":"2010","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"issue":"5","key":"10.1016\/bs.apha.2023.03.002_bib37","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1440-1843.2012.02135.x","article-title":"Low-dose azithromycin improves phagocytosis of bacteria by both alveolar and monocyte-derived macrophages in chronic obstructive pulmonary disease subjects","volume":"17","author":"Hodge","year":"2012","journal-title":"Respirology (Carlton, Vic.)"},{"issue":"3","key":"10.1016\/bs.apha.2023.03.002_bib38","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1183\/09031936.06.00001506","article-title":"Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages","volume":"28","author":"Hodge","year":"2006","journal-title":"The European Respiratory Journal: Official Journal of the European Society for Clinical Respiratory Physiology"},{"issue":"1","key":"10.1016\/bs.apha.2023.03.002_bib39","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/resp.12415","article-title":"Increased CD8 T-cell granzyme B in COPD is suppressed by treatment with low-dose azithromycin","volume":"20","author":"Hodge","year":"2015","journal-title":"Respirology (Carlton, Vic.)"},{"issue":"2","key":"10.1016\/bs.apha.2023.03.002_bib40","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1164\/rccm.200711-1666OC","article-title":"Azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease","volume":"178","author":"Hodge","year":"2008","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/bs.apha.2023.03.002_bib41","doi-asserted-by":"crossref","first-page":"L678","DOI":"10.1152\/ajplung.00518.2016","article-title":"Nonantibiotic macrolides restore airway macrophage phagocytic function with potential anti-inflammatory effects in chronic lung diseases","volume":"312","author":"Hodge","year":"2017","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"10.1016\/bs.apha.2023.03.002_bib42","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00588-2019","article-title":"Management of severe asthma: A European Respiratory Society\/American Thoracic Society guideline","volume":"55","author":"Holguin","year":"2020","journal-title":"The European Respiratory Journal: Official Journal of the European Society for Clinical Respiratory Physiology"},{"issue":"1","key":"10.1016\/bs.apha.2023.03.002_bib43","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jdermsci.2016.07.007","article-title":"Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice","volume":"84","author":"Huang","year":"2016","journal-title":"Journal of Dermatological Science"},{"issue":"3","key":"10.1016\/bs.apha.2023.03.002_bib44","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/cei.12023","article-title":"Efficacy of azithromycin in preventing lethal graft-versus-host disease","volume":"171","author":"Iwamoto","year":"2013","journal-title":"Clinical and Experimental Immunology"},{"issue":"3","key":"10.1016\/bs.apha.2023.03.002_bib45","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2249.2011.04480.x","article-title":"The effect of azithromycin on the maturation and function of murine bone marrow-derived dendritic cells","volume":"166","author":"Iwamoto","year":"2011","journal-title":"Clinical and Experimental Immunology"},{"issue":"3 Suppl 2","key":"10.1016\/bs.apha.2023.03.002_bib46","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1016\/j.jaci.2009.07.015","article-title":"Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis","volume":"124","author":"Jensen","year":"2009","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"1","key":"10.1016\/bs.apha.2023.03.002_bib47","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s12931-020-01489-8","article-title":"Azithromycin ameliorates sulfur dioxide-induced airway epithelial damage and inflammatory responses","volume":"21","author":"Joelsson","year":"2020","journal-title":"Respiratory Research"},{"issue":"4","key":"10.1016\/bs.apha.2023.03.002_bib48","first-page":"545","article-title":"Azithromycin has lung barrier protective effects in a cell model mimicking ventilator-induced lung injury","volume":"37","author":"Joelsson","year":"2020","journal-title":"ALTEX: Alternativen zu Tierexperimenten"},{"key":"10.1016\/bs.apha.2023.03.002_bib49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.pupt.2015.12.002","article-title":"Long-term azithromycin ameliorates not only airway inflammation but also remodeling in a murine model of chronic asthma","volume":"36","author":"Kang","year":"2016","journal-title":"Pulmonary Pharmacology & Therapeutics"},{"issue":"3","key":"10.1016\/bs.apha.2023.03.002_bib50","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1128\/CMR.00078-09","article-title":"Mechanisms of action and clinical application of macrolides as immunomodulatory medications","volume":"23","author":"Kanoh","year":"2010","journal-title":"Clinical Microbiology Reviews"},{"issue":"3","key":"10.1016\/bs.apha.2023.03.002_bib51","article-title":"Macrolide antibiotics for bronchiectasis","volume":"3","author":"Kelly","year":"2018","journal-title":"Cochrane Database of Systematic Reviews (Online)"},{"key":"10.1016\/bs.apha.2023.03.002_bib52","doi-asserted-by":"crossref","unstructured":"Kricker,\u00a0J. A.,\u00a0Gardarsson,\u00a0F. R.,\u00a0Lehmann,\u00a0F.,\u00a0Bech,\u00a0M.,\u00a0Gudjonsson,\u00a0T.,\u00a0Page,\u00a0C. P., et al.\u00a0(2022a). Inhibition of neutrophilic inflammation by targeting the airway epithelial barrier with EP395.\u00a0Paper presented at the European Respiratory Society, Barcelona, Spain.","DOI":"10.1183\/13993003.congress-2022.312"},{"issue":"4","key":"10.1016\/bs.apha.2023.03.002_bib53","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1124\/pharmrev.121.000300","article-title":"Nonantimicrobial actions of macrolides: Overview and perspectives for future development","volume":"73","author":"Kricker","year":"2021","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/bs.apha.2023.03.002_bib54","unstructured":"Kricker,\u00a0J. A.,\u00a0Valdimarsdottir,\u00a0B.,\u00a0Joelsson,\u00a0J. P.,\u00a0Ingthorsson,\u00a0S.,\u00a0Parnham,\u00a0M. J.,\u00a0Sigurdsson,\u00a0S.,\u00a0et al. (2022b). Barriolides: Non-antibacterial compounds with epithelial barrier enhancing properties and anti-inflammatory effects in vitro.\u00a0Paper presented at the 15th World Congress on Inflammation, Rome, Italy. (Poster retrieved from; http:\/\/www.pharmadvances.com\/wp-content\/uploads\/2022\/05\/PhAdv_Special-Issue_WCI-2022.pdf) p. 19."},{"issue":"Suppl 9A","key":"10.1016\/bs.apha.2023.03.002_bib55","first-page":"12S","article-title":"Applying lessons learned in the treatment of diffuse panbronchiolitis to other chronic inflammatory diseases","volume":"117","author":"Kudoh","year":"2004","journal-title":"The American Journal of Medicine"},{"key":"10.1016\/bs.apha.2023.03.002_bib56","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/636157","article-title":"Macrolide therapy in chronic inflammatory diseases","volume":"2012","author":"Kwiatkowska","year":"2012","journal-title":"Mediators of Inflammation"},{"issue":"5","key":"10.1016\/bs.apha.2023.03.002_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/toxins13050347","article-title":"Macrolides: From toxins to therapeutics","volume":"13","author":"Lenz","year":"2021","journal-title":"Toxins (Basel)"},{"key":"10.1016\/bs.apha.2023.03.002_bib58","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/1471-2180-12-196","article-title":"Macrolides decrease the minimal inhibitory concentration of anti-pseudomonal agents against Pseudomonas aeruginosa from cystic fibrosis patients in biofilm","volume":"12","author":"Lutz","year":"2012","journal-title":"BMC Microbiology"},{"issue":"5","key":"10.1016\/bs.apha.2023.03.002_bib59","first-page":"L683","article-title":"Azithromycin inhibits mucin secretion, mucous metaplasia, airway inflammation, and airways hyperresponsiveness in mice exposed to house dust mite extract","volume":"322","author":"Mann","year":"2022","journal-title":"American Journal of"},{"key":"10.1016\/bs.apha.2023.03.002_bib60","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejphar.2011.04.036","article-title":"Development of non-antibiotic macrolide that corrects inflammation-driven immune dysfunction in models of inflammatory bowel diseases and arthritis","volume":"665","author":"Mencarelli","year":"2011","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/bs.apha.2023.03.002_bib61","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.4049\/jimmunol.0902866","article-title":"A new strategy for the identification of novel molecules with targeted proresolution of inflammation properties","volume":"184","author":"Navarro-Xavier","year":"2010","journal-title":"Journal of Immunology"},{"key":"10.1016\/bs.apha.2023.03.002_bib62","unstructured":"NICE. (2023). COVID-19 rapid guideline: Managing COVID-19. Retrieved from \u3008https:\/\/www.nice.org.uk\/guidance\/ng191\/resources\/covid19-rapid-guideline-managing-covid19-pdf-51035553326\u3009."},{"issue":"1","key":"10.1016\/bs.apha.2023.03.002_bib63","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.cellimm.2012.09.007","article-title":"Impairment of lysosomal functions by azithromycin and chloroquine contributes to anti-inflammatory phenotype","volume":"279","author":"Nujic","year":"2012","journal-title":"Cellular Immunology"},{"issue":"1\u20133","key":"10.1016\/bs.apha.2023.03.002_bib64","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejphar.2011.12.022","article-title":"Valosin containing protein (VCP) interacts with macrolide antibiotics without mediating their anti-inflammatory activities","volume":"677","author":"Nujic","year":"2012","journal-title":"European Journal of Pharmacology"},{"issue":"2","key":"10.1016\/bs.apha.2023.03.002_bib65","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2163","article-title":"Azithromycin in viral infections","volume":"31","author":"Oliver","year":"2021","journal-title":"Reviews in Medical Virology"},{"issue":"10","key":"10.1016\/bs.apha.2023.03.002_bib66","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.tcb.2020.08.004","article-title":"Tight junction structure and function revisited","volume":"30","author":"Otani","year":"2020","journal-title":"Trends in Cell Biology"},{"issue":"5","key":"10.1016\/bs.apha.2023.03.002_bib67","article-title":"Tight junctions as a key for pathogens invasion in intestinal epithelial cells","volume":"22","author":"Paradis","year":"2021","journal-title":"International Journal of Molecular\u00a0Sciences"},{"issue":"2","key":"10.1016\/bs.apha.2023.03.002_bib68","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pharmthera.2014.03.003","article-title":"Azithromycin: Mechanisms of action and their relevance for clinical applications","volume":"143","author":"Parnham","year":"2014","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/bs.apha.2023.03.002_bib69","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3389\/fmicb.2016.00974","article-title":"Mycoplasma pneumoniae: Current knowledge on macrolide resistance and treatment","volume":"7","author":"Pereyre","year":"2016","journal-title":"Frontiers in Microbiology"},{"key":"10.1016\/bs.apha.2023.03.002_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2021.102095","article-title":"The immunomodulatory effects of macrolide antibiotics in respiratory disease","volume":"71","author":"Pollock","year":"2021","journal-title":"Pulmonary Pharmacology & Therapeutics"},{"issue":"5","key":"10.1016\/bs.apha.2023.03.002_bib71","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.chest.2018.01.044","article-title":"Clinical and safety outcomes of long-term azithromycin therapy in severe COPD beyond the first year of treatment","volume":"153","author":"Pomares","year":"2018","journal-title":"Chest"},{"issue":"1","key":"10.1016\/bs.apha.2023.03.002_bib72","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bbmt.2014.09.025","article-title":"Preventive azithromycin treatment reduces noninfectious lung injury and acute graft-versus-host disease in a murine model of allogeneic hematopoietic cell transplantation","volume":"21","author":"Radhakrishnan","year":"2015","journal-title":"Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation"},{"key":"10.1016\/bs.apha.2023.03.002_bib73","doi-asserted-by":"crossref","first-page":"7438","DOI":"10.1038\/srep07438","article-title":"Azithromycin suppresses CD4(+) T-cell activation by direct modulation of mTOR activity","volume":"4","author":"Ratzinger","year":"2014","journal-title":"Scientific Reports"},{"issue":"6","key":"10.1016\/bs.apha.2023.03.002_bib74","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2213-2600(20)30080-1","article-title":"Immunomodulation by macrolides: Therapeutic potential for critical care","volume":"8","author":"Reijnders","year":"2020","journal-title":"The\u00a0Lancet Respiratory Medicine"},{"issue":"3","key":"10.1016\/bs.apha.2023.03.002_bib75","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3934\/microbiol.2018.3.482","article-title":"An overview of the antimicrobial resistance mechanisms of bacteria","volume":"4","author":"Reygaert","year":"2018","journal-title":"AIMS Microbiology"},{"issue":"1","key":"10.1016\/bs.apha.2023.03.002_bib76","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00011-019-01302-3","article-title":"The non-antibiotic macrolide EM900 attenuates HDM and poly(I:C)-induced airway inflammation with inhibition of macrophages in a mouse model","volume":"69","author":"Sadamatsu","year":"2020","journal-title":"Inflammation Research: Official Journal of the European Histamine Research Society"},{"issue":"9","key":"10.1016\/bs.apha.2023.03.002_bib77","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1159\/000508709","article-title":"The nonantibiotic macrolide EM900 attenuates house dust mite-induced airway inflammation in a mouse model of obesity-associated asthma","volume":"181","author":"Sadamatsu","year":"2020","journal-title":"International Archives of Allergy and Immunology"},{"issue":"1","key":"10.1016\/bs.apha.2023.03.002_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2011.10.027","article-title":"Azithromycin fails to reduce inflammation in cystic fibrosis airway epithelial cells","volume":"674","author":"Saint-Criq","year":"2012","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/bs.apha.2023.03.002_bib79","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12931-016-0358-z","article-title":"Regeneration of the lung: Lung stem cells and the development of lung mimicking devices","volume":"17","author":"Schilders","year":"2016","journal-title":"Respiratory Research"},{"issue":"11","key":"10.1016\/bs.apha.2023.03.002_bib80","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1164\/rccm.200801-145OC","article-title":"Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations","volume":"178","author":"Seemungal","year":"2008","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/bs.apha.2023.03.002_bib81","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1749-6632.2012.06613.x","article-title":"Tight junctions on the move: Molecular mechanisms for epithelial barrier regulation","volume":"1258","author":"Shen","year":"2012","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/bs.apha.2023.03.002_bib82","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ejphar.2018.06.017","article-title":"An in vitro test system for compounds that modulate human inflammatory macrophage polarization","volume":"833","author":"Shiratori","year":"2018","journal-title":"European Journal of Pharmacology"},{"issue":"7","key":"10.1016\/bs.apha.2023.03.002_bib83","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1136\/thoraxjnl-2020-216331","article-title":"Add-on azithromycin reduces sputum cytokines in non-eosinophilic asthma: an AMAZES substudy","volume":"76","author":"Shukla","year":"2021","journal-title":"Thorax"},{"issue":"8","key":"10.1016\/bs.apha.2023.03.002_bib84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105609","article-title":"The effect of azithromycin in adults with stable neutrophilic COPD: A double blind randomised, placebo controlled trial","volume":"9","author":"Simpson","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/bs.apha.2023.03.002_bib85","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1164\/rccm.200707-1134OC","article-title":"Clarithromycin targets neutrophilic airway inflammation in refractory asthma","volume":"177","author":"Simpson","year":"2008","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"18","key":"10.1016\/bs.apha.2023.03.002_bib86","article-title":"The differential effects of azithromycin on the airway epithelium in vitro and in vivo","volume":"4","author":"Slater","year":"2016","journal-title":"Physiological\u00a0Reports"},{"issue":"1","key":"10.1016\/bs.apha.2023.03.002_bib87","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1128\/AAC.00607-07","article-title":"Subinhibitory concentrations of azithromycin decrease nontypeable Haemophilus influenzae biofilm formation and diminish established biofilms","volume":"52","author":"Starner","year":"2008","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"11","key":"10.1016\/bs.apha.2023.03.002_bib88","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1016\/j.bmcl.2011.04.004","article-title":"Novel 12-membered non-antibiotic macrolides from erythromycin A; EM900 series as novel leads for anti-inflammatory and\/or immunomodulatory agents","volume":"21","author":"Sugawara","year":"2011","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"issue":"Suppl 9A","key":"10.1016\/bs.apha.2023.03.002_bib89","first-page":"5S","article-title":"Clinical implications of the immunomodulatory effects of macrolides","volume":"117","author":"Tamaoki","year":"2004","journal-title":"The American Journal of Medicine"},{"issue":"11","key":"10.1016\/bs.apha.2023.03.002_bib90","doi-asserted-by":"crossref","first-page":"L746","DOI":"10.1152\/ajplung.00292.2012","article-title":"Nonantibiotic macrolides prevent human neutrophil elastase-induced mucus stasis and airway surface liquid volume depletion","volume":"304","author":"Tarran","year":"2013","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"issue":"3","key":"10.1016\/bs.apha.2023.03.002_bib91","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1164\/rccm.201809-1739OC","article-title":"Long-term azithromycin reduces haemophilus influenzae and increases antibiotic resistance in severe asthma","volume":"200","author":"Taylor","year":"2019","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/bs.apha.2023.03.002_bib92","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.bmc.2012.10.036","article-title":"Macrolactonolides: a novel class of anti-inflammatory compounds","volume":"21","author":"Tomaskovic","year":"2013","journal-title":"Bioorg Med Chem"},{"issue":"10","key":"10.1016\/bs.apha.2023.03.002_bib93","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41429-019-0204-x","article-title":"Azithromycin, a 15-membered macrolide antibiotic, inhibits influenza A(H1N1)pdm09 virus infection by interfering with virus internalization process","volume":"72","author":"Tran","year":"2019","journal-title":"The Journal of Antibiotics"},{"issue":"5","key":"10.1016\/bs.apha.2023.03.002_bib94","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S2213-2600(14)70019-0","article-title":"Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): A randomised, double-blind, placebo-controlled trial","volume":"2","author":"Uzun","year":"2014","journal-title":"The\u00a0Lancet Respiratory Medicine"},{"issue":"1","key":"10.1016\/bs.apha.2023.03.002_bib95","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1600-6143.2006.01586.x","article-title":"Macrolides inhibit IL17-induced IL8 and 8-isoprostane release from human airway smooth muscle cells","volume":"7","author":"Vanaudenaerde","year":"2007","journal-title":"American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons"},{"issue":"5","key":"10.1016\/bs.apha.2023.03.002_bib96","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/j.1476-5381.2011.01576.x","article-title":"Azithromycin distinctively modulates classical activation of human monocytes in vitro","volume":"165","author":"Vrancic","year":"2012","journal-title":"British Journal of Pharmacology"},{"issue":"3","key":"10.1016\/bs.apha.2023.03.002_bib97","first-page":"131","article-title":"Effects of low-dose clarithromycin added to fluticasone on inflammatory markers and pulmonary function among children with asthma: A randomized clinical trial","volume":"7","author":"Wan","year":"2016","journal-title":"Allergy & Rhinology (Providence)"},{"issue":"2","key":"10.1016\/bs.apha.2023.03.002_bib98","first-page":"119","article-title":"Study effect of azithromycin and doxycycline in mucus producing and inflammatory signaling pathways of allergic asthma","volume":"21","author":"Wang","year":"2022","journal-title":"Iranian Journal of Allergy, Asthma, and Immunology"},{"issue":"6","key":"10.1016\/bs.apha.2023.03.002_bib99","doi-asserted-by":"crossref","DOI":"10.1177\/0300060520932104","article-title":"Mechanism of azithromycin in airway diseases","volume":"48","author":"Yang","year":"2020","journal-title":"The Journal of International Medical Research"},{"key":"10.1016\/bs.apha.2023.03.002_bib100","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3389\/fimmu.2018.00302","article-title":"The immunomodulatory effects of macrolides\u2014A systematic review of the underlying mechanisms","volume":"9","author":"Zimmermann","year":"2018","journal-title":"Frontiers in Immunology"}],"container-title":["Advances in Pharmacology","Pulmonary Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358923000170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358923000170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T04:31:08Z","timestamp":1715315468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054358923000170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9780443188800"],"references-count":100,"URL":"https:\/\/doi.org\/10.1016\/bs.apha.2023.03.002","relation":{},"ISSN":["1054-3589"],"issn-type":[{"value":"1054-3589","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]}}}